The NF-κB pathway has been widely recognized to play a critical role in immune-mediated inflammatory diseases, including rheumatoid arthritis19, inflammatory bowel disease (IBD)20, and multiple sclerosis (MS)21. Here, NFKB1 is linked to multiple sclerosis.